Home226950 • KOSDAQ
add
OliX Pharmaceuticals Inc
Previous close
₩47,000.00
Day range
₩42,800.00 - ₩47,550.00
Year range
₩8,280.00 - ₩64,000.00
Market cap
861.22B KRW
Avg Volume
583.19K
P/E ratio
-
Dividend yield
-
Primary exchange
KOSDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (KRW) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 976.55M | 27.09% |
Operating expense | 9.15B | -15.35% |
Net income | -13.27B | -57.82% |
Net profit margin | -1.36K | -24.18% |
Earnings per share | — | — |
EBITDA | -7.60B | 19.48% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (KRW) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 11.54B | -64.68% |
Total assets | 68.96B | -32.30% |
Total liabilities | 42.99B | -33.75% |
Total equity | 25.97B | — |
Shares outstanding | 19.78M | — |
Price to book | 36.70 | — |
Return on assets | -29.39% | — |
Return on capital | -36.74% | — |
Cash Flow
Net change in cash
| (KRW) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -13.27B | -57.82% |
Cash from operations | -677.13M | 89.47% |
Cash from investing | 1.03B | -91.14% |
Cash from financing | 3.97B | -72.45% |
Net change in cash | 4.41B | -77.57% |
Free cash flow | -5.49B | 47.53% |
About
CEO
Founded
2010
Website
Employees
66
